Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib plus chemotherapy as adjuvant therapy for locally advanced gastric cancer
ChiCTR2000038900Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2019
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Rivoceranib in gastric adenocarcinoma (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Disease-free survival (DFS). Started Jan 2019; status: recruiting.
02
Drugs
Rivoceranib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR2000038900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038900.